| 摘要 |
FIELD: chemistry. ^ SUBSTANCE: described are compounds of formula (I) ^ Values of radicals R1-R6 are given in the formula of invention. The compounds inhibit protein kinase MEK1/2. Also described is a pharmaceutical composition for administration in diseases mediated by MEK1/2. ^ EFFECT: compounds are highly efficient. ^ 16 cl, 27 ex |
